Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · IEX Real-Time Price · USD
28.95
-2.57 (-8.14%)
Jun 14, 2024, 11:06 AM EDT - Market open

Corcept Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2001
Revenue
482.38401.86365.98353.87306.49
Upgrade
Revenue Growth (YoY)
20.04%9.80%3.42%15.46%21.99%
Upgrade
Cost of Revenue
6.485.395.285.585.5
Upgrade
Gross Profit
475.89396.47360.7348.29300.98
Upgrade
Selling, General & Admin
184.26152.85122.36105.33100.36
Upgrade
Research & Development
184.35130.99113.86114.7689.02
Upgrade
Operating Expenses
368.61283.84236.22220.09189.38
Upgrade
Operating Income
107.28112.63124.48128.2111.61
Upgrade
Interest Expense / Income
-17.28-3.56-0.53-3.4-5.07
Upgrade
Other Expense / Income
0.640.13---
Upgrade
Pretax Income
123.91116.06125.01131.6116.68
Upgrade
Income Tax
18.4214.7712.4925.5922.5
Upgrade
Net Income
105.5101.29112.51106.0194.18
Upgrade
Net Income Growth
4.15%-9.98%6.13%12.56%24.89%
Upgrade
Shares Outstanding (Basic)
104107116115114
Upgrade
Shares Outstanding (Diluted)
112116126124123
Upgrade
Shares Change
-3.64%-7.94%1.42%1.33%-3.25%
Upgrade
EPS (Basic)
1.020.950.970.920.82
Upgrade
EPS (Diluted)
0.940.870.890.850.77
Upgrade
EPS Growth
8.05%-2.25%4.71%10.39%28.33%
Upgrade
Free Cash Flow
126.9119.91167.42150.73135.03
Upgrade
Free Cash Flow Per Share
1.231.121.451.311.18
Upgrade
Gross Margin
98.66%98.66%98.56%98.42%98.20%
Upgrade
Operating Margin
22.24%28.03%34.01%36.23%36.41%
Upgrade
Profit Margin
21.87%25.20%30.74%29.96%30.73%
Upgrade
Free Cash Flow Margin
26.31%29.84%45.75%42.59%44.06%
Upgrade
Effective Tax Rate
14.86%12.73%9.99%19.45%19.28%
Upgrade
EBITDA
109115.95127.95130.44113.78
Upgrade
EBITDA Margin
22.60%28.85%34.96%36.86%37.12%
Upgrade
Depreciation & Amortization
2.363.453.482.242.17
Upgrade
EBIT
106.64112.5124.48128.2111.61
Upgrade
EBIT Margin
22.11%28.00%34.01%36.23%36.41%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).